XML 81 R68.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Unconsolidated Subsidiaries - Statements of Operations (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Equity Method Investment, Summarized Financial Information [Abstract]      
Gross profit $ 380,024 $ 316,260 $ 246,081
Operating income 78,458 46,038 31,409
Net income $ 64,853 437,416 116,464
ULVAC Cryogenics, Inc.      
Equity Method Investment, Summarized Financial Information [Abstract]      
Total revenue   88,357 94,652
Gross profit   35,127 34,982
Operating income   17,791 18,405
Net income   $ 12,483 $ 13,345